We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRAC.WS
501
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$8K ﹤0.01%
91,586
+61,586
+205% +$13.2K
EUCRW
502
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$8K ﹤0.01%
122,257
-64,970
-35% -$10.4K
KSICW
503
DELISTED
Kadem Sustainable Impact Corporation Warrant
KSICW
$8K ﹤0.01%
+78,134
New +$14.9K
FTAAW
504
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$8K ﹤0.01%
28,700
-800
-3% -$266
JCICW
505
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$8K ﹤0.01%
+104,402
New +$15.7K
FVT.WS
506
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$8K ﹤0.01%
+42,500
New +$16.1K
FUBO icon
507
CALL
FuboTV Inc
FUBO
$283M
$7K ﹤0.01%
+12,500
New +$582K
TGT icon
508
CALL
Target
TGT
$69B
$7K ﹤0.01%
19,700
PRLHW
509
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$7K ﹤0.01%
42,425
+8,408
+25% +$2.06K
AWINW
510
DELISTED
AERWINS Technologies Inc Warrant
AWINW
$7K ﹤0.01%
114,500
+89,500
+358% +$13.1K
ASCAW
511
DELISTED
A SPAC I Acquisition Corp. Warrant
ASCAW
$7K ﹤0.01%
131,701
+7,801
+6% +$935
SHAP.WS
512
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$7K ﹤0.01%
63,000
+13,000
+26% +$2.33K
CORS.WS
513
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$7K ﹤0.01%
34,777
-12,267
-26% -$3.77K
GVCIW
514
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
$7K ﹤0.01%
50,000
BMAQW
515
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
$7K ﹤0.01%
56,660
+38,700
+215% +$5.5K
SCOAW
516
DELISTED
ScION Tech Growth I Warrant
SCOAW
$7K ﹤0.01%
50,900
-25,443
-33% -$4.87K
COLIW
517
DELISTED
Colicity Inc. Warrant
COLIW
$7K ﹤0.01%
30,688
-10,664
-26% -$3.02K
KLAQW
518
DELISTED
KL Acquisition Corp Warrant
KLAQW
$7K ﹤0.01%
50,000
TWNI.WS
519
DELISTED
Tailwind International Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TWNI.WS
$7K ﹤0.01%
90,500
+3
+0%
AGBAR
520
DELISTED
AGBA Acquisition Ltd Right
AGBAR
$7K ﹤0.01%
50,279
-17,819
-26% -$2.84K
ETACW
521
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$7K ﹤0.01%
50,000
-700
-1% -$100
DNA icon
522
CALL
Ginkgo Bioworks
DNA
$515M
$6K ﹤0.01%
+3,365
New +$410K
GEVO icon
523
CALL
Gevo
GEVO
$388M
$6K ﹤0.01%
+81,100
New +$297K
MBI icon
524
PUT
MBIA
MBI
$257M
$6K ﹤0.01%
+9,400
New +$124K
PRENW
525
Prenetics Global Ltd Warrant
PRENW
$119K
$6K ﹤0.01%
+13,555
New +$5.05K

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.